Gunmakudori mezhugu for Abdominal pain during menstural cycle

Efficacy of Gunmakudori mezhugu a Siddha treatment in Primary dysmenorrhoea (Soothaga vaayu)- a pilot study - Not applicable

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/057141

Enrollment

Registered

2023-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R52- Pain, unspecified

Interventions

Intervention1: Gunmakudori Mezhugu: GunmaKudori mezhugu for primary dysmenorrhoea. Duration of the study is 1year Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 15 to 30 years. 2. Regular menstrual cycle with Spasmodic dysmenorrhoeal pain with WALIDD Score range of 5-12 (moderate to severe range) 3. Patient willing to participate in trial and sign the informed consent. 4. Patient willing to take USG Scan

Exclusion criteria

Exclusion criteria: 1. Presence of any pelvic pathology such as Chronic pelvic infection, Pelvic endometriosis, Adenomyosis, Uterine fibroid, Endometrial Polyp. 2. IUCD in utero. 3. Dysfunctional uterine bleeding. 4. Presence of any associated severe systemic illness cardiovascular disease, respiratory disease etc., 5. Abdominal pain presenting other than the gynaecological complaints

Design outcomes

Primary

Measure	Time frame
Efficacy of GunmaKudori mezhugu will be assessed on the basis of reduction of pain which will be calculated using WALIDD scoreTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Preliminary data for Larger studyTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDharshini priya

National Institute of Siddha

dramalaaruldhas@gmail.com9994998821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026